| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |